Singular Sleep fills in-lab gap at home

 - 
Monday, August 3, 2020

JACKSONVILLE BEACH, Fla. – Due to the risk of COVID-19, in-lab studies are problematic right now, delaying appointments by months, says Joseph Krainin, president and founder of Singular Sleep.

To help combat that, Singular Sleep has launched a new program to help patients find the required pressure for their CPAP machines in their own homes.

“Large healthcare systems like Kaiser Permanente have been doing a variation of this process for quite a long-time for their patient populations,” said Krainin. “It's a cost-effective way of managing sleep apnea patients.”

Instead of spending a night in a sleep lab, Singular Sleep sends an auto-titrating CPAP machine (APAP) to the patient’s home that has been sterilized and outfitted with new air filters, tubing and water chambers. The patient uses the machine for a week and then returns it to Singular Sleep.

Singular Sleep offers U.S.-based customer support by phone, email and chat, as well as an “on-call" person on weekends and holidays. The company doesn’t accept insurance, but it does assist patients seeking reimbursement through their insurance.
“In-lab titration studies can also be astronomically expensive, especially for cash-pay patients,” said Krainin. “Our in-home titration program achieves similar results at a fraction of the cost.”
In the wake of COVID-19, Krainin says he's seen a steady shift toward the remote management of sleep patients. While Singular Sleep has been at the forefront of that since 2015, the pandemic caused an inflection point and brought sleep telemedicine to the mainstream.
"I don't think we'll ever go back to 'sleep medicine as usual,'" he said.